Study of Codivir in Patients With COVID-19

Summary

This is an open-label study to evaluate the safety and preliminary efficacy of Codivir in 12 mild or moderate COVID-19 patients and onset of symptoms within 72h prior to their inclusion. Treatment will begin in the hospital, participants will be discharged at Day 4 and continue the treatment up to Day 10 at home and followed up to day 28.

Timeline

Start

2021-03-29

Primary completion

2021-05-27

Completion

2021-08-09

Drugs

Indications